CausalSentinel

Protein Dossier — CFH (Complement factor H)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Forced vital capacity (FVC) -0.0206 0.00548 1.66e-04 Wald ratio 1 cis NA
Sleep duration -0.0188 0.00521 3.21e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: kidney stone or ureter stone or bladder stone 0.206 0.0617 8.61e-04 Wald ratio 1 cis NA
IgA nephropathy -0.702 0.229 0.00216 Wald ratio 1 cis NA
Serum cystatin C (eGFRcys) 0.0136 0.00491 0.00547 Wald ratio 1 cis NA
Non-cancer illness code self-reported: asthma 0.0488 0.0178 0.00612 Wald ratio 1 cis NA
Hearing difficulty or problems: Yes 0.0298 0.0112 0.00775 Wald ratio 1 cis NA
Non-cancer illness code self-reported: enlarged prostate 0.128 0.0504 0.0111 Wald ratio 1 cis NA
Coronary heart disease -0.0636 0.0252 0.0117 Wald ratio 1 cis NA
Diastolic blood pressure automated reading 0.0168 0.00684 0.0143 Wald ratio 1 cis NA
Body fat -0.036 0.0147 0.0145 Wald ratio 1 cis NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.197 0.0809 0.0149 Wald ratio 1 cis NA
…and 107 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4159_130_1 Factor H Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

2077 association rows across 1877 traits (2029 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Ribosomal protein S6 kinase alpha-1 levels 3e-2377 rs10801553 1 GCST90248212 no MR -> candidate analysis
Thiosulfate sulfurtransferase levels 6e-1871 rs12033127 2 GCST90249867 no MR -> candidate analysis
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitoc 2e-1862 rs12033127 1 GCST90248580 no MR -> candidate analysis
Glycosyltransferase 8 domain-containing protein 1 levels 1e-1005 rs34813609 1 GCST90247734 no MR -> candidate analysis
Advanced age-related macular degeneration 1e-617 rs10922109 5 GCST003219 no MR -> candidate analysis
Leucine-rich repeat transmembrane neuronal protein 1 levels 2e-561 rs12029785 1 GCST90248335 no MR -> candidate analysis
Alpha-N-acetylglucosaminidase levels 3e-464 rs529541 2 GCST90248587 no MR -> candidate analysis
Age-related macular degeneration 1e-434 rs10737680 18 GCST001884 no MR -> candidate analysis
Age-related macular degeneration (MTAG) 4e-421 rs800292 1 GCST010284 no MR -> candidate analysis
Anaphase-promoting complex subunit 7 levels (ANAPC7.11690.47 4e-401 rs528298 2 GCST90240278 no MR -> candidate analysis
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitoc 6e-394 rs10801553 1 GCST90242029 no MR -> candidate analysis
Otoraplin levels 7e-378 rs529541 1 GCST90248801 no MR -> candidate analysis
…and 1865 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 2174 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
complement factor H deficiency 0.947 established (curated) no MR -> candidate analysis
age-related macular degeneration 0.832 0.152 established (curated) no MR -> candidate analysis
atypical hemolytic-uremic syndrome 0.917 established (curated) no MR -> candidate analysis
age related macular degeneration 4 0.851 established (curated) no MR -> candidate analysis
Familial drusen 0.845 established (curated) no MR -> candidate analysis
retinal disorder 0.813 0.312 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
degeneration of macula and posterior pole 0.767 0.222 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
macular degeneration 0.95 common-variant locus no MR -> candidate analysis
dense deposit disease 0.549 established (curated) no MR -> candidate analysis
wet macular degeneration 0.895 common-variant locus no MR -> candidate analysis
atypical hemolytic-uremic syndrome with H factor anomaly 0.91 established (curated) no MR -> candidate analysis
dry age related macular degeneration 0.863 common-variant locus no MR -> candidate analysis
complement 3 glomerulopathy 0.195 established (curated) no MR -> candidate analysis
Visual impairment 0.822 common-variant locus no MR -> candidate analysis
Retinal dystrophy 0.797 established (curated) no MR -> candidate analysis

Of the 15 rows above, 15 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 2 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Complement factor H)
gnomAD constraint pLI=1, LOEUF=0.452 — LoF-INTOLERANT
GWAS Catalog 175 unique SNPs / 469 rows
ClinVar 1628 records; 8 pathogenic in sample of 30
PharmGKB/ClinPGx 4 clinical annotations across 3 drugs

Caveats declared by the tools

Sources

Provenance